Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 110
Filter
1.
Article in English | WPRIM | ID: wpr-812993

ABSTRACT

OBJECTIVES@#To explore the expression of autophagy related genes 5 (ATG5) and cyclin E in coronary heart disease (CHD) and its clinical significance.@*METHODS@#From April 2018 to August 2018, 80 patients diagnosed with CHD in the Second Xiangya Hospital, Central South University were selected as an observation group, and another 80 healthy subjects were selected as a control group. The expression of ATG5 and cyclin E mRNA in nucleate cells and the plasma protein in the 2 groups were detected and analyzed. The model of macrophage-derived foam cells induced by oxidized low density lipoprotein (ox-LDL) was used to simulate atherosclerosis. The proliferation of macrophage- derived foam cells and the protein levels of ATG5 and cyclin E induced by ox-LDL at different concentrations were examined.@*RESULTS@#Compared with the control group, the levels of ATG5 mRNA and protein in the blood in the observation group were decreased, and the cyclin E mRNA and protein levels were increased, there were statistically difference (both <0.05). Receiver operating characteristic (ROC) curve showed that the area under curve (AUC) of ATG5 mRNA, cyclin E mRNA, ATG5 protein and cyclin E protein were 0.739, 0.780, 0.671 and 0.807, respectively. Pearson analysis showed that the ATG5 mRNA was negatively correlated with the cyclin E mRNA (=-0.734, <0.05),while the plasma ATG5 protein was negatively correlated with the plasma cyclin E protein (=-0.746, <0.05). Macrophage-derived foam cell model induced by ox-LDL showed that the proliferation of foam cells and the expression levels of cyclin E protein were increased in a concentration and time-dependent manner, and the expression levels of ATG5 protein were decreased in a concentration-dependent manner.@*CONCLUSIONS@#The levels of ATG5 mRNA and protein are lowly expressed while the levels of cyclin E mRNA and protein are highly expressed in the patients with CHD.The ATG5 protein levels are lowly expressed in ox-LDL-treated macrophage-derived foam cells while the cyclin E protein levels are highly expressed in ox-LDL-treated macrophage-derived foam cells. Based on these observations, we conclude that ATG5 inhibits the degradation of the cyclin E and promotes the proliferation of macrophages, involving in the occurrence and development of CHD.


Subject(s)
Autophagy , Autophagy-Related Protein 5 , Coronary Disease , Cyclin E , Foam Cells , Humans , Lipoproteins, LDL
2.
Yonsei Medical Journal ; : 509-516, 2019.
Article in English | WPRIM | ID: wpr-762085

ABSTRACT

PURPOSE: This study was conducted to verify the induction and mechanism of selective apoptosis in G361 melanoma cells using anti-HER2 antibody-conjugated gold nanoparticles (GNP-HER2). MATERIALS AND METHODS: Following GNP-HER2 treatment of G361 cells, cell cycle arrest and apoptosis were measured by WST-1 assay, Hemacolor staining, Hoechst staining, immunofluorescence staining, fluorescence-activated cell sorting analysis, and Western blotting.


Subject(s)
Actins , Apoptosis Inducing Factor , Apoptosis , Blotting, Western , Caspase 3 , Caspases , Cell Adhesion , Cell Cycle , Cell Cycle Checkpoints , Cell Death , Cyclin A , Cyclin D1 , Cyclin E , Cyclins , Cytochromes c , Cytoplasm , DNA Fragmentation , Down-Regulation , Flow Cytometry , Fluorescent Antibody Technique , Focal Adhesions , Melanoma , Mitochondria , Nanoparticles , Phosphotransferases , ErbB Receptors , Up-Regulation
3.
Article in English | WPRIM | ID: wpr-764309

ABSTRACT

BACKGROUND: Helicobacter pylori infection is a major risk factor in the development of gastric cancer. H. pylori infection of gastric epithelial cells increases the levels of reactive oxygen species (ROS), activates oncogenes, and leads to β-catenin-mediated hyper-proliferation. β-Carotene reduces ROS levels, inhibits oxidant-mediated activation of inflammatory signaling and exhibits anticancer properties. The present study was carried out to determine if β-carotene inhibits H. pylori-induced cell proliferation and the expression of oncogenes c-myc and cyclin E by reducing the levels of β-catenin and phosphorylated glycogen synthase kinase 3β (p-GSK3β). METHODS: Gastric epithelial AGS cells were pre-treated with β-carotene (5 and 10 μM) for 2 hours prior to H. pylori infection and cultured for 6 hours (for determination of the levels of p-GSK3β, GSK3β, and β-catenin) and 24 hours (for determination of cell viability and protein levels of c-myc and cyclin E). Cell viability was determined by the MTT assay and protein levels were determined via western blot-based analysis. RESULTS: β-Carotene inhibited H. pylori-induced increases in the percentage of viable cells, phosphorylated GSK3β (p-GSK3β), and the levels of β-catenin, c-myc and cyclin E. CONCLUSIONS: β-Carotene inhibits H. pylori-induced hyper-proliferation of gastric epithelial cells by suppressing β-catenin signaling and oncogene expression.


Subject(s)
beta Carotene , beta Catenin , Cell Proliferation , Cell Survival , Cyclin E , Cyclins , Epithelial Cells , Glycogen Synthase Kinases , Helicobacter pylori , Helicobacter , Oncogenes , Reactive Oxygen Species , Risk Factors , Stomach Neoplasms
4.
Chinese Journal of Lung Cancer ; (12): 271-279, 2019.
Article in Chinese | WPRIM | ID: wpr-775632

ABSTRACT

BACKGROUND@#Cyclic RNA (circRNA) is a new type of non-coding RNA (ncRNA) which is different from traditional linear RNA. More and more studies suggest that circRNA can be used as a biological marker of many malignant tumors and becomes a potential target for treatment. Therefore, searching for new molecular targets of lung adenocarcinoma from the circRNA will help to reveal the new mechanism of the occurrence and development of lung adenocarcinoma, and provide new ideas for clinical diagnosis and treatment. In this study, the biological function of circ_0007766, a highly expressed circRNA found in a screen of lung adenocarcinoma tissue, was verified and analyzed in vitro, so as to preliminarily explore the mechanism of circ_0007766 in promoting the proliferation of lung adenocarcinoma.@*METHODS@#The expression level of circ_0007766 in lung adenocarcinoma cells was detected by qPCR. Then siRNA was used to knock down the expression of circ_0007766. The effects of knockdown of circ_0007766 on proliferation, cell cycle and apoptosis of lung adenocarcinoma cells were detected by CCK8, scratch test, PI staining and Annexin V/PI double staining. In addition, the biological mechanism of circ_0007766 in lung adenocarcinoma was preliminarily studied by qPCR and Western blots.@*RESULTS@#The expression of circ_0007766 in lung adenocarcinoma cell lines was detected by qPCR. The expression of circ_0007766 was interfered in SPCA-1 cells. The proliferation and migration abilities of cells were inhibited. The cell cycle was arrested in G0/G1 phase, but the apoptosis was not affected. The deletion of circ_0007766 did not affect the expression of ERBB2, but influenced the mRNA and protein expression of Cyclin D1/Cyclin E1/CDK4.@*CONCLUSIONS@#In vitro functional studies have shown that circ_0007766 may promote the proliferation and migration of lung adenocarcinoma cells. Further molecular mechanism studies have found that circ_0007766 can up-regulate the expression of Cyclin D1/Cyclin E1/CDK4, which are the key proteins of cell cycle, and thus promote the malignant proliferation of lung adenocarcinoma. From the perspective of circRNA, this study will provide new clues for the pathogenesis, development and prognosis of lung adenocarcinoma, and provide new target for clinical treatment.


Subject(s)
Adenocarcinoma of Lung , Pathology , Apoptosis , Genetics , Cell Cycle , Genetics , Cell Line, Tumor , Cell Proliferation , Genetics , Cell-Free Nucleic Acids , Genetics , Cyclin D1 , Genetics , Cyclin E , Genetics , Cyclin-Dependent Kinase 4 , Genetics , Humans , Oncogene Proteins , Genetics , Up-Regulation , Genetics
5.
Article in English | WPRIM | ID: wpr-740103

ABSTRACT

BACKGROUND: 15,16-dihydrotanshinone I (DHTS) is a natural abietane diterpenoid that is mainly found in the roots of Salvia miltiorrhiza Bunge (Labiatae). DHTS exhibits a potential anti-proliferative effect in various human cancer cells. However, the mechanisms of action of DHTS as an anti-cancer agent have not been fully elucidated. Therefore, the present study investigated the anti-cancer effect of DHTS in terms of cell cycle regulation and the regulation of the AMP-activated protein kinase (AMPK)/Akt/mTOR signaling pathway in SK-HEP-1 human hepatocellular carcinoma cells. METHODS: The anti-proliferative effects of DHTS were evaluated by the sulforhodamine B assay in SK-HEP-1 cells. Cell cycle distribution was analyzed by flow cytometry. The elucidation of mechanisms of action such as the AMPK/AKT/mTOR and mitogen-activated protein kinase (MAPK) pathway was assessed by Western blot analysis. RESULTS: DHTS showed a significant anti-proliferative activity against SK-HEP-1 cells. DHTS induced cell cycle arrest in the G0/G1 phase, which was mediated by downregulation of cyclin D1, cyclin A, cyclin E, CDK4, CDK2, c-Myc and p-Rb expression and with increased expression of the CDK inhibitor p21. DHTS also activated the AMPK signaling. In addition, DHTS downregulated the Akt/mTOR and MAPK signaling pathways. CONCLUSIONS: Our results suggest that the anti-proliferative activity of DHTS might be associated with the induction of G0/G1 phase cell cycle arrest and regulation of AMPK/Akt/mTOR and MAPK signaling pathways in SK-HEP-1 cells.


Subject(s)
AMP-Activated Protein Kinases , Blotting, Western , Carcinoma, Hepatocellular , Cell Cycle Checkpoints , Cell Cycle , Cyclin A , Cyclin D1 , Cyclin E , Cyclins , Down-Regulation , Flow Cytometry , Humans , Protein Kinases , Salvia miltiorrhiza
6.
Journal of Breast Cancer ; : 103-111, 2018.
Article in English | WPRIM | ID: wpr-714871

ABSTRACT

PURPOSE: Chloride channel-3 (ClC-3) is a member of the chloride channel family and plays a critical role in a variety of cellular activities. The aim of the present study is to explore the molecular mechanisms underlying the antitumor effect of silencing ClC-3 in breast cancer. METHODS: Human breast cancer cell lines MDA-MB-231 and MCF-7 were used in the experiments. Messenger RNA and protein expression were examined by quantitative real-time polymerase chain reaction and western blot analysis. Cell proliferation was measured by the bromodeoxyuridine method, and the cell cycle was evaluated using fluorescence-activated cell sorting. Protein interaction in cells was analyzed by co-immunoprecipitation. Tumor tissues were stained with hematoxylin-eosin and tumor burden was measured using the Metamorph software. RESULTS: Breast cancer tissues collected from patients showed an increase in ClC-3 expression. Knockdown of ClC-3 inhibited the secretion of insulin-like growth factor (IGF)-1, cell proliferation, and G1/S transition in breast cancer cells. In the mouse xenograft model of human breast carcinoma, tumor growth was significantly slower in animals injected with ClC-3-deficient cells compared with the growth of normal human breast cancer cells. In addition, silencing of ClC-3 attenuated the expression of proliferating cell nuclear antigen, Ki-67, cyclin D1, and cyclin E, as well as the activation of extracellular signal-regulated protein kinases (ERK) 1/2, both in vitro and in vivo. CONCLUSION: Together, our data suggest that upregulation of ClC-3 by IGF-1 contributes to cell proliferation and tumor growth in breast cancer, and ClC-3 deficiency suppresses cell proliferation and tumor growth via the IGF/IGF receptor/ERK pathway.


Subject(s)
Animals , Blotting, Western , Breast Neoplasms , Breast , Bromodeoxyuridine , Cell Cycle , Cell Line , Cell Proliferation , Chloride Channels , Cyclin D1 , Cyclin E , Cyclins , Flow Cytometry , Heterografts , Humans , Immunoprecipitation , In Vitro Techniques , Insulin-Like Growth Factor I , Methods , Mice , Proliferating Cell Nuclear Antigen , Protein Kinases , Real-Time Polymerase Chain Reaction , RNA, Messenger , Tumor Burden , Up-Regulation
7.
Article in English | WPRIM | ID: wpr-714734

ABSTRACT

Anti-cancer drug resistance is a major problem in colorectal cancer (CRC) research. Although several studies have revealed the mechanism of cancer drug resistance, molecular targets for chemotherapeutic combinations remain elusive. To address this issue, we focused on the expression of cellular prion protein (PrPC) in 5-FU-resistant CRC cells. In 5-FU-resistant CRC cells, PrPC expression is significantly increased, compared with that in normal CRC cells. In the presence of 5-FU, PrPC increased CRC cell survival and proliferation by maintaining the activation of the PI3K-Akt signaling pathway and the expression of cell cycle-associated proteins, including cyclin E, CDK2, cyclin D1, and CDK4. In addition, PrPC inhibited the activation of the stress-associated proteins p38, JNK, and p53. Moreover, after treatment of 5-FU-resistant CRC cells with 5-FU, silencing of PrPC triggered apoptosis via the activation of caspase-3. These results indicate that PrPC plays a key role in CRC drug resistance. The novel strategy of combining chemotherapy with PrPC targeting may yield efficacious treatments of colorectal cancer.


Subject(s)
Apoptosis , Caspase 3 , Cell Survival , Colorectal Neoplasms , Cyclin D1 , Cyclin E , Cyclins , Drug Resistance , Drug Therapy , Fluorouracil , Signal Transduction
8.
Rio de Janeiro; s.n; 2017. xIII, 86 f p.
Thesis in Portuguese | LILACS, Inca | ID: biblio-1118572

ABSTRACT

A ciclina E, juntamente com Cdk2, é um regulador importante da transição das fases G1/S do ciclo celular, promovendo o início e a progressão da síntese de DNA. Em alguns tipos de câncer, como o câncer de mama, os níveis de ciclina E se encontram desregulados, correlacionando com um estágio avançado do tumor e mau prognóstico. Níveis elevados de ciclina E interferem com a montagem de complexos pré-replicativos e retardam a progressão das forquilhas de replicação, levando ao fenômeno de estresse replicativo e eventualmente a instabilidade genômica. No entanto, as alterações genômicas causadas pela desregulação da ciclina E ainda não foram totalmente investigadas. Dados anteriores do nosso grupo demonstraram que altos níveis de ciclina E1 retardam a progressão pela fase S, permitindo que células entrem em mitose antes do término da replicação do DNA. A replicação incompleta do DNA induz aberrações cromossômicas em regiões genômicas específicas, como sítios frágeis. O objetivo deste projeto é avaliar o efeito da desregulação de ciclina E1 na instabilidade genômica de células epiteliais da mama ao longo da proliferação celular. Para estabelecer o modelo de estresse replicativo, células do epitélio da mama humana imortalizadas (HME1) foram transduzidas com adenovírus controle (Adv-Controle) ou com adenovírus que codifica o cDNA de ciclina E1 humana (Adv-Ciclina E1). Como controle positivo, foram utilizadas as linhagens celulares de câncer da mama SUM149PT e MDA-MB-157, que têm níveis aumentados de ciclina E1. Nossos resultados indicam que altos níveis de ciclina E1 não interferem com a proliferação de células HME1. Contudo, análises de citometria de fluxo indicam que altos níveis de ciclina E1 reduzem o número de células na fase G1, reduzem a progressão pela fase S e atrasam a entrada nas fases G2/M ao longo de 7 dias. A desregulação de ciclina E1 não induz a morte celular, mas induz eventos de poliploidia. Células HME1 tratadas com a afidicolina, um inibidor de DNA polimerase, progridem mais lentamente pela fase S, mas não apresentam alterações na morte celular ou poliploidia. Além disso, células HME1 com desregulação de ciclina E1 apresentam aberrações cromossômicas, como endorreduplicação, hiperfragmentação cromossômica e separação prematura de cromátides irmãs quando comparadas com células controle. No momento, estamos avaliando a instabilidade de sítios frágeis específicos em células HME1 com altos níveis de ciclina E1 usando Hibridização Fluorescente In Situ (FISH). Além disso, células HME1 com níveis elevados de ciclina E1 serão analisadas através de cariótipo por bandeamento G. O objetivo deste projeto é contribuir para a caracterização das alterações genéticas mediadas por ciclina E1 durante a carcinogênese da mama.


Subject(s)
Breast Neoplasms/genetics , Cyclin E , Cell Cycle , Genomic Instability
9.
Article in Chinese | WPRIM | ID: wpr-272509

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the effects of AMPK agonist Acadesine (AICAR) on growth inhibition of K562 cells and their sensitivity to imatinib (IM).</p><p><b>METHODS</b>K562 cells were cultured with different concentrations of AICAR alone or its combination with IM for 48 hours, the CCK-8 assay was used to detect cell proliferation, the cell cycle distribution and apoptosis were analyzed by flow cytometry. The expression levels of Cyclin D1, Cyclin E1 and Caspase 3 protein were determined by Western blot.</p><p><b>RESULTS</b>AICAR inhibited the proliferation of K562 cells in dose-dependent manner, and their IC50 value was 0.45 mmol/L at 48 hours. AICAR could induce arrest of K562 cells in G1 phase and down-regulated the protein expression levels of Cyclin D1 and Cyclin E1; whereas it didn't influence the cell apoptosis. Additionally, the growth inhibition of cells induced by IM was enhanced by AICAR.</p><p><b>CONCLUSION</b>AICAR can inhibit the proliferation of K562 cells by arresting the cell cycle and enhancing the sensitivity of K562 cells to IM.</p>


Subject(s)
Aminoimidazole Carboxamide , Pharmacology , Apoptosis , Caspase 3 , Metabolism , Cell Cycle Checkpoints , Cell Proliferation , Cyclin D1 , Metabolism , Cyclin E , Metabolism , Humans , Imatinib Mesylate , Pharmacology , K562 Cells , Oncogene Proteins , Metabolism , Ribonucleosides , Pharmacology
10.
Article in English | WPRIM | ID: wpr-68878

ABSTRACT

Cardiovascular disease is the most common cause of death in diabetic patients. Hyperglycemia is the primary characteristic of diabetes and is associated with many complications. The role of hyperglycemia in the dysfunction of human cardiac progenitor cells that can regenerate damaged cardiac tissue has been investigated, but the exact mechanism underlying this association is not clear. Thus, we examined whether hyperglycemia could regulate mitochondrial dynamics and lead to cardiac progenitor cell dysfunction, and whether blocking glucose uptake could rescue this dysfunction. High glucose in cardiac progenitor cells results in reduced cell viability and decreased expression of cell cycle-related molecules, including CDK2 and cyclin E. A tube formation assay revealed that hyperglycemia led to a significant decrease in the tube-forming ability of cardiac progenitor cells. Fluorescent labeling of cardiac progenitor cell mitochondria revealed that hyperglycemia alters mitochondrial dynamics and increases expression of fission-related proteins, including Fis1 and Drp1. Moreover, we showed that specific blockage of GLUT1 improved cell viability, tube formation, and regulation of mitochondrial dynamics in cardiac progenitor cells. To our knowledge, this study is the first to demonstrate that high glucose leads to cardiac progenitor cell dysfunction through an increase in mitochondrial fission, and that a GLUT1 blocker can rescue cardiac progenitor cell dysfunction and downregulation of mitochondrial fission. Combined therapy with cardiac progenitor cells and a GLUT1 blocker may provide a novel strategy for cardiac progenitor cell therapy in cardiovascular disease patients with diabetes.


Subject(s)
Cardiovascular Diseases , Cause of Death , Cell Survival , Cyclin E , Cyclins , Diabetic Cardiomyopathies , Down-Regulation , Glucose , Humans , Hyperglycemia , Mitochondria , Mitochondrial Dynamics , Stem Cells
11.
Cancer Research and Treatment ; : 1302-1312, 2016.
Article in English | WPRIM | ID: wpr-109746

ABSTRACT

PURPOSE: TRIM29 overexpression has been reported in several human malignancies and showed correlation with cancer cell malignancy. The aim of the current study is to examine its clinical significance and biological roles in human bladder cancer tissues and cell lines. MATERIALS AND METHODS: A total of 102 cases of bladder cancer tissues were examined for TRIM29 expression by immunohistochemistry. siRNA and plasmid transfection were performed in 5637 and BIU-87 cell lines. Cell Counting Kit-8, flow cytometry, western blot, and real-time polymerase chain reaction were performed to examine its biological roles and mechanism in bladder cancer cells. RESULTS: We found that TRIM29 overexpression showed correlation with invading depth (p=0.0087). Knockdown of TRIM29 expression in bladder cancer cell line 5637 inhibited cell growth rate and cell cycle transition while its overexpression in BIU-87 cells accelerated cell proliferation and cell cycle progression. TRIM29 overexpression also inhibited cell apoptosis induced by cisplatin. In addition, we demonstrated that TRIM29 depletion decreased while its overexpression led to upregulated expression of cyclin D1, cyclin E, and Bcl-2. We also showed that TRIM29 knockdown inhibited protein kinase C (PKC) and nuclear factor κB (NF-κB) signaling while its overexpression stimulated the PKC and NF-κB pathways. BAY 11-7082 (NF-κB inhibitor) partly attenuated the effect of TRIM29 on expression of cyclin and Bcl-2. Treatment with PKC inhibitor staurosporine resulted in ameliorated TRIM29 induced activation of NF-κB. CONCLUSION: The current study demonstrated that TRIM29 upregulates cyclin and Bcl family proteins level to facilitate malignant cell growth and inhibit drug-induced apoptosis in bladder cancer, possibly through PKC–NF-κB signaling pathways.


Subject(s)
Apoptosis , Bays , Blotting, Western , Cell Count , Cell Cycle , Cell Line , Cell Proliferation , Cisplatin , Cyclin D1 , Cyclin E , Cyclins , Flow Cytometry , Humans , Immunohistochemistry , Plasmids , Protein Kinase C , Real-Time Polymerase Chain Reaction , RNA, Small Interfering , Staurosporine , Transfection , Urinary Bladder Neoplasms , Urinary Bladder
12.
Article in Chinese | WPRIM | ID: wpr-355307

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the effect of emodin on proliferation and cell cycle distribution of human oral squamous carcinoma cells in vitro.</p><p><b>METHODS</b>Cultured human oral squamous carcinoma Tca8113 cells were treated with 2.5, 5, 10, 20, 40, 60 and 80 µmol/L emodin for 24, 48 or 72 h, with the cells treated with 0.1% DMSO as control. MTT assay and flow cytometry were used to evaluate the changes in cell proliferation and cell cycle distribution, respectively. Western blotting was employed to analyze the changes in the expression levels of the cell cycle-related proteins CDK2, cyclin E and P21 after emodin treatment.</p><p><b>RESULTS</b>Emodin significantly inhibited the growth and proliferation of Tca8113 cells within 72 h in a time- and dose-dependent manner, and caused cell cycle arrest in G0-G1 phase. Western blotting revealed that emodin treatment significantly lowered the expression levels of CDK2, cyclin E and P21 proteins in Tca8113 cells (P<0.05).</p><p><b>CONCLUSION</b>Emodin can inhibit the proliferation of Tca8113 cells and affect their cell cycle distribution possibly by inhibiting the signaling pathways of cell cycle regulation.</p>


Subject(s)
Carcinoma, Squamous Cell , Pathology , Cell Cycle , Cell Line, Tumor , Cell Proliferation , Cyclin E , Metabolism , Cyclin-Dependent Kinase 2 , Metabolism , Cyclin-Dependent Kinase Inhibitor p21 , Metabolism , Emodin , Pharmacology , Humans , Mouth Neoplasms , Pathology , Oncogene Proteins , Metabolism , Signal Transduction
13.
Article in English | WPRIM | ID: wpr-250383

ABSTRACT

This study aimed to evaluate the effects of Pin1 inhibitor Juglone on proliferation, migration and the angiogenic ability of breast cancer cell line MCF7Adr. MCF7Adr cells were cultured and separately treated with Pin1 inhibitor Juglone (treatment group) and DMEM without drug (control group). The cell cycle was examined by flow cytometry. Cell migration was measured by wound-healing assay. Cyclin E protein content was detected by Western blotting. The angiogenesis factor vascular endothelial growth factor (VEGF) in cell media was determined by enzyme linked immunosorbent assay. The results showed that the percentage of cells in G2/M phase in treatment group was significantly higher than that in control group (25.5% vs. 10.1%, P<0.05), and that in G0/G1 phase and S stage in treatment group was significantly lower than that in control group (40.5% vs. 48.2%, and 33.7% vs. 41.7%, P<0.05). Cyclin E protein content in treatment group was significantly lower than that in control group (39.2 ± 7.4 vs. 100 ± 23.1, P<0.05). (A0-A24)/A0 value in treatment group was significantly lower than that in control group (23.9 ± 3.8 vs. 100 ± 14.4, P<0.05). VEGF-A, -B, and -C contents in cell media of treatment group were significantly lower than those in control group (P<0.05). It was suggested that Pin1 inhibitor Juglone can effectively inhibit the proliferation, migration and the angiogenic ability of MCF7Adr cells, and can be used as an alternative drug therapy for breast cancer.


Subject(s)
Antineoplastic Agents , Pharmacology , Breast Neoplasms , Drug Therapy , Metabolism , Cell Cycle , Cell Movement , Cell Proliferation , Cyclin E , Metabolism , Female , Gene Expression Regulation, Neoplastic , Humans , MCF-7 Cells , NIMA-Interacting Peptidylprolyl Isomerase , Naphthoquinones , Pharmacology , Peptidylprolyl Isomerase , Vascular Endothelial Growth Factor A , Metabolism
14.
Article in English | WPRIM | ID: wpr-250350

ABSTRACT

Bmi1 is a member of the polycomb group family of proteins, and it drives the carcinogenesis of various cancers and governs the self-renewal of multiple types of stem cells. However, its role in the initiation and progression of bladder cancer is not clearly known. The present study aimed to investigate the function of Bmi1 in the development of bladder cancer. Bmi1 expression was detected in human bladder cancer tissues and their adjacent normal tissues (n=10) by immunohistochemistry, qRT-PCR and Western blotting, respectively. Bmi1 small interference RNA (siRNA) was synthesized and transfected into human bladder carcinoma cells (EJ) by lipofectamine 2000. The Bmil expression at mRNA and protein levels was measured in EJ cells transfected with Bmil siRNA (0, 80, 160 nmol/L) by qRT-PCR and Western blotting, respectively. Cell viability and Ki67 expression (a marker of cell proliferation) were determined in Bmi1 siRNA-transfected cells by CCK-8 assay and qRT-PCR, respectively. Cell cycle of transfected cells was flow-cytometrically determined. Immunofluorescence and Western blotting were used to detect the expression levels of cell cycle-associated proteins cyclin D1 and cyclin E in the cells. Pro-apoptotic proteins Bax and caspase 3 and anti-apoptotic protein Bcl-2 were detected by Western blotting as well. Additionally, xenograft tumor models were established by inoculation of EJ cells (infected with Bmil shRNA/pLKO.1 lentivirus or not) into nude mice. The tumor volumes were measured every other day for 14 days. The results showed that the Bmil expression was significantly increased in bladder tumor tissues when compared with that in normal tissues (P<0.05). Perturbation of Bmi1 expression by using siRNA could significantly inhibit the proliferation of EJ cells (P<0.05). Bmi1 siRNA-transfected EJ cells were accumulated in G1 phase and the expression levels of cyclin D1 and cyclin E were down-regulated. Bax and caspase-3 expression levels were significantly increased and Bcl-2 levels decreased after Bmi1 knockdown. Tumor volume was conspicuously reduced in mice injected with EJ cells with Bmi1 knockdown. Our findings indicate that Bmi1 is a potential driver oncogene of bladder cancer and it may become a potential treatment target for human bladder cancer.


Subject(s)
Animals , Apoptosis , Genetics , Carcinogenesis , Genetics , Metabolism , Pathology , Carcinoma , Genetics , Metabolism , Pathology , Therapeutics , Caspase 3 , Genetics , Metabolism , Cell Line, Tumor , Cyclin D1 , Genetics , Metabolism , Cyclin E , Genetics , Metabolism , G1 Phase Cell Cycle Checkpoints , Genetics , Gene Expression Regulation, Neoplastic , Humans , Injections, Intralesional , Ki-67 Antigen , Genetics , Metabolism , Mice , Mice, Nude , Polycomb Repressive Complex 1 , Genetics , Metabolism , Proto-Oncogene Proteins c-bcl-2 , Genetics , Metabolism , RNA, Small Interfering , Genetics , Metabolism , Signal Transduction , Tumor Burden , Urinary Bladder , Metabolism , Pathology , Urinary Bladder Neoplasms , Genetics , Metabolism , Pathology , Therapeutics , Xenograft Model Antitumor Assays , bcl-2-Associated X Protein , Genetics , Metabolism
15.
Article in English | WPRIM | ID: wpr-727355

ABSTRACT

The increased potential for vascular smooth muscle cell (VSMC) growth is a key abnormality in the development of atherosclerosis and post-angioplasty restenosis. Abnormally high activity of platelet-derived growth factor (PDGF) is believed to play a central role in the etiology of these pathophysiological situations. Here, we investigated the anti-proliferative effects and possible mechanism(s) of murrayafoline A, a carbazole alkaloid isolated from Glycosmis stenocarpa Guillamin (Rutaceae), on PDGF-BB-stimulated VSMCs. Murrayafoline A inhibited the PDGF-BB-stimulated proliferation of VSMCs in a concentration-dependent manner, as measured using a non-radioactive colorimetric WST-1 assay and direct cell counting. Furthermore, murrayafoline A suppressed the PDGF-BB-stimulated progression through G0/G1 to S phase of the cell cycle, as measured by [3H]-thymidine incorporation assay and cell cycle progression analysis. This anti-proliferative action of murrayafoline A, arresting cell cycle progression at G0/G1 phase in PDGF-BB-stimulated VSMCs, was mediated via down-regulation of the expression of cyclin D1, cyclin E, cyclin-dependent kinase (CDK)2, CDK4, and proliferating cell nuclear antigen (PCNA), and the phosphorylation of retinoblastoma protein (pRb). These results indicate that murrayafoline A may be useful in preventing the progression of vascular complications such as restenosis after percutaneous transluminal coronary angioplasty and atherosclerosis.


Subject(s)
Angioplasty, Balloon, Coronary , Atherosclerosis , Cell Count , Cell Cycle , Cyclin D1 , Cyclin E , Cyclins , Down-Regulation , Muscle, Smooth, Vascular , Phosphorylation , Phosphotransferases , Platelet-Derived Growth Factor , Proliferating Cell Nuclear Antigen , Retinoblastoma Protein , Rutaceae , S Phase
16.
Article in English | WPRIM | ID: wpr-42472

ABSTRACT

An F-box protein, beta-TrCP recognizes substrate proteins and destabilizes them through ubiquitin-dependent proteolysis. It regulates the stability of diverse proteins and functions as either a tumor suppressor or an oncogene. Although the regulation by beta-TrCP has been widely studied, the regulation of beta-TrCP itself is not well understood yet. In this study, we found that the level of beta-TrCP1 is downregulated by various protein kinase inhibitors in triple-negative breast cancer (TNBC) cells. A PI3K/mTOR inhibitor PI-103 reduced the level of beta-TrCP1 in a wide range of TNBC cells in a proteasome-dependent manner. Concomitantly, the levels of c-Myc and cyclin E were also downregulated by PI-103. PI-103 reduced the phosphorylation of beta-TrCP1 prior to its degradation. In addition, knockdown of beta-TrCP1 inhibited the proliferation of TNBC cells. We further identified that pharmacological inhibition of mTORC2 was sufficient to reduce the beta-TrCP1 and c-Myc levels. These results suggest that mTORC2 regulates the stability of beta-TrCP1 in TNBC cells and targeting beta-TrCP1 is a potential approach to treat human TNBC.


Subject(s)
Cell Line, Tumor , Cell Proliferation , Cell Survival/drug effects , Cyclin E/genetics , Dose-Response Relationship, Drug , Female , Furans/pharmacology , Gene Knockdown Techniques , Humans , Models, Biological , Multiprotein Complexes/antagonists & inhibitors , Phosphatidylinositol 3-Kinases/antagonists & inhibitors , Phosphorylation/drug effects , Protein Kinase Inhibitors/pharmacology , Proteolysis/drug effects , Proto-Oncogene Proteins c-myc/genetics , Pyridines/pharmacology , Pyrimidines/pharmacology , TOR Serine-Threonine Kinases/antagonists & inhibitors , Triple Negative Breast Neoplasms/genetics , beta-Transducin Repeat-Containing Proteins/genetics
17.
Article in Chinese | WPRIM | ID: wpr-748515

ABSTRACT

OBJECTIVE@#To explore new hallmarks affecting the prognosis of patients with laryngeal squamous cell carcinoma (LSCC) via investigating the expression of CyclinE and p27 in LSCC tissues.@*METHOD@#The expression of CyclinE and p27 was detected via Elivision immunohistochemical staining in 160 LSCC tissues and 20 normal laryngeal tissues (NLT). The relationship between CyclinE/ p27 and LSCC/ NLT was analyzed via Log-rank analysis. The relationship of CyclinE and p27 protein was statistically analyzed by spearman correlation analysis. The relationship between CyclinE/p27 and clinical-pathology-factors of patients with LSCC, such as age, gender, tumor site, diameter, differentiation, lymph node metastasis and PTNM stage were analyzed by Chi-square test. The relationship between clinical-pathology-factors, CyclinE, p27 and overall survival time of patients with LSCC was analyzed via Cox multiplicity and Kaplan-Meier survival analysis. A significant difference was recognized by P0.05 for all). A negative correlation was found between the expression of CyclinE and p27 protein, r= -0.767(P<0.05). Kaplan-Meier survival analysis showed that the overall survival rate of patients with LSCC was 36.9% (P<0.05). The 5-year survival rate in positive group of CyclinE was 8%, in negative group was 80% (P<0.05). On the contrary, the 5-year survival rate of patients with LSCC in positive group of p27 protein was 77.27%, the rate was 5.32% in negative group (P<0.05). Cox multivariate regression analysis revealed that lymph node metastasis, PTNM stage, CyclinE and p27 were independent risk factors of prognosis for patients with LSCC.@*CONCLUSION@#It is the molecular basis underlying the development and invasion/ metastasis of LSCC that activation of CyclinE gene accompanying inactivation of p27 gene. It is very important of co-detecting CyclinE and p27 protein to predict the prognosis of patients with LSCC.


Subject(s)
Carcinoma, Squamous Cell , Metabolism , Pathology , Cyclin E , Metabolism , Cyclin-Dependent Kinase Inhibitor p27 , Metabolism , Female , Head and Neck Neoplasms , Metabolism , Pathology , Humans , Laryngeal Mucosa , Metabolism , Pathology , Laryngeal Neoplasms , Metabolism , Pathology , Lymphatic Metastasis , Male , Middle Aged , Oncogene Proteins , Metabolism , Prognosis , Squamous Cell Carcinoma of Head and Neck , Survival Rate
18.
Article in Chinese | WPRIM | ID: wpr-748161

ABSTRACT

OBJECTIVE@#To investigate the expression and clinicopathological significance of the cell cycle regulators cyclin E, cyclin D1, p21, p16 in laryngeal carcinogenesis tissus.@*METHOD@#The expression of cell cycle regulators were detected by flow cytometry method in 23 cases of polyps of vocal cord, 69 cases of laryngeal precancerous change and 33 cases of laryngeal squamous cell carcinoma (LSCC), which tissue was paraffin embedded, sliced, dewaxed, and prepared into the cell suspension, then fluorescently labeled by cyclin E, cyclin D1, p21 and p16.@*RESULT@#In polyps of vocal cord, laryngeal precancerous change and LSCC, The positive expression rate of cyclin E and cyclin D1 were respectively 13.04%, 20.29D, 42.420 and 26.09%, 43.48% and 93.94%. The positive expression rate of p16 and p21 were respectively 61.90%, 40.98%, 14.28% and 47.62%, 23.81%, 26.23%. Those showed the positive expression rate of cyclin D1, cyclin E gradually decreased from vocal cord polyps, laryngeal precancerous change to LSCC, (P < 0.05, P < 0.01), while the positive expression rate of p21 and p16 gradually decreased (P < 0.01).@*CONCLUSION@#The abnormal expression of cell cycle regulatory factors is the molecular events of laryngeal carcinoma. High expression of positive regulatory factors cyclin D1 and cyclin E, and low expression of negative regulatory factors p16 and p21, which showed the imbalance of multiple positive and negative regulatory factors related with cell cycle play an important role in the occurrence of laryngeal cancer.


Subject(s)
Adult , Cyclin D1 , Metabolism , Cyclin E , Metabolism , Cyclin-Dependent Kinase Inhibitor p16 , Metabolism , Cyclin-Dependent Kinase Inhibitor p21 , Metabolism , Female , Flow Cytometry , Humans , Laryngeal Neoplasms , Metabolism , Pathology , Male , Middle Aged , Oncogene Proteins , Metabolism
19.
Journal of Experimental Hematology ; (6): 1311-1315, 2014.
Article in Chinese | WPRIM | ID: wpr-340507

ABSTRACT

This study was aimed to investigate the effect of MEK inhibitor AZD8330 on proliferation and apoptosis of multiple myeloma IM9 and NCI-H929 cell lines and its possible mechanism. These two cell line cells were exposed to different concentrations of AZD8330 for 48 h. The CCK-8 assay was used to detect cell viability and the IC50 value at 48 h. These above-mentioned IM9 and NCI-H929 cells were treated with 5,10 and 100 nmol/L of AZD8330, then the change of cell cycle was analysed by flow cytometry with PI staining. The Wester blot was used to detect the expression levels of cyclin D and cyclin E, and multiple myeloma cells were treated with 10, 100, 1000 and 2000 nmol/L of AZD8330, the AnnexinV/7-AAD double staining was used to analyse cell apoptosis and the Western blot was used to detect the expression level of caspase-3. The results showed that AZD8330 could significantly inhibit the cell viability of IM9 and NCI-H929 cell lines in a time-and dose-dependent manner, the IC50 value (48 h) of IM9 and NCI-H929 were 19.88 ± 2.7 nmol/L and 29.3 ± 2.03 nmol/L respectively, these two cell lines were arrested on G1 phase of cell cycle, the apoptosis cells increased along with enhancement of AZD8330 concentration, and the expression level of cleaved caspase-3 protein was up-regulated. It is concluded that AZD8330 can efficiently inhibit the proliferation of NCI-H929 and IM9 cell lines, and induce apoptosis, suggesting that the AZD8330 may be a potential chemotherapeutic candidate for multiple myeloma therapy.


Subject(s)
Apoptosis , Caspase 3 , Cell Cycle , Cell Line, Tumor , Cell Proliferation , Cyclin E , Dihydropyridines , Pharmacology , Humans , Multiple Myeloma , Pathology , Oncogene Proteins , Protein Kinase Inhibitors , Pharmacology
20.
Journal of Experimental Hematology ; (6): 1577-1583, 2014.
Article in Chinese | WPRIM | ID: wpr-340455

ABSTRACT

This study was aimed to investigate the effect of Honokiol (HNK) on proliferation and apoptosis of acute myeloid leukemia HL-60 cells and its potential mechanism. Inhibitory effect of HNK on the HL-60 cell proliferation was detected by MTT assay. Flow cytometry was used to detect the change of cell cycle and AnnexinV/PI staining was used to detect apoptosis. Western blot was applied to analyze the cell cycle protein (cyclins), cyclin-dependent kinase (CDK), P53, P21, P27, BCL-2, BCL-XL, Bax, caspase-3/9 and proteins for MAPK signal pathway. The results showed that HNK could inhibit the proliferation of HL-60 cells in time- and dose dependent ways. HNK arrested HL-60 cells in G0/G1 phase, and S phase cells decreased significantly (P < 0.05). The expression of cyclin D1, cyclin A, cyclin E and CDK2/4/6 were significantly down-regulated (P < 0.05), the expression of P53 and P21 was significantly upregulated after treating for 24 h with HNK (P < 0.05). After 24 h treatment with HNK, HL-60 cell apoptosis increased significantly with the upregulation of activated caspase-3, -9, BAX expression and the downregulation of BCL-2, BCL-XL expression. The MAPK subfamily, P38 and JNK were not significantly changed, but the expression of MEK1/2-ERK1/2 was significantly downregulated (P < 0.05). It is concluded that HNK arrestes the cells at G0/G1 phase and induces HL-60 cell apoptosis through the intervention of MEK1/2-ERK1/2 signaling pathway.


Subject(s)
Apoptosis , Biphenyl Compounds , Pharmacology , Caspase 3 , Cell Cycle , Cell Proliferation , Cyclin D1 , Cyclin E , Cyclin-Dependent Kinase 2 , HL-60 Cells , Humans , Lignans , Pharmacology , Oncogene Proteins , Signal Transduction , bcl-2-Associated X Protein
SELECTION OF CITATIONS
SEARCH DETAIL